Clinical Trials Logo

Clinical Trial Summary

The aim of this trial is to demonstrate the effectiveness of complete wound healing in a prospective, open-label, randomized trial in which venous leg ulcers (VLU)n will be treated using Aurix and compared to patients receiving undefined Usual and Customary Care (UCC)


Clinical Trial Description

Recurrence of ulcers in the leg is common; two-thirds of patients are likely to experience recurring ulcers after the first ulcer. While treatment of the underlying venous disease, depending on the mode of treatment, can lower the recurrence rate in many patients, it does not affect recurrence. Aurix is a platelet-rich plasma (PRP) gel used in the treatment of non-healing chronic wounds. The aim of this trial is to demonstrate the effectiveness, measured as complete wound healing, in a prospective, randomized trial in which venous leg ulcers will be treated using Aurix and standard of care and compared 1:1 to patients receiving undefined Usual and Customary Care (UCC). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02352454
Study type Interventional
Source Nuo Therapeutics
Contact Stacy Gardner
Phone 240-406-1816
Email sgardner@nuot.com
Status Recruiting
Phase N/A
Start date February 2015
Completion date July 2018

See also
  Status Clinical Trial Phase
Completed NCT00663091 - A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers Phase 1
Recruiting NCT02609594 - Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers N/A
Unknown status NCT02011724 - A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf® Phase 4
Active, not recruiting NCT01737762 - Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2 Phase 3
Completed NCT02222467 - Safety Evaluation of the KLOX BioPhotonic System in Venous Leg Ulcers N/A
Completed NCT01199588 - A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers Phase 2
Withdrawn NCT00953563 - The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers N/A
Enrolling by invitation NCT02047084 - Comparison of Human Allograft to Apligraf for Venous Leg Ulcers
Completed NCT02020746 - Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds Phase 2
Terminated NCT02154087 - A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers Phase 2
Completed NCT02470806 - Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT) N/A
Suspended NCT02577120 - Wound Healing Endpoint and Recurrence Phase 4
Completed NCT01743053 - A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers Phase 4
Recruiting NCT02312518 - A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Venous Leg Ulcers N/A
Withdrawn NCT02940587 - Effectiveness of Aurix Therapy in Venous Leg Ulcers Phase 4
Completed NCT01036438 - Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers Phase 4
Unknown status NCT02224300 - Nursing Care With Patients With Venous Leg Ulcers Phase 2
Completed NCT01656889 - Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers Phase 3
Completed NCT02422017 - Topical Timolol Benefit in Venous Ulcers Phase 2